🇺🇸 FDA
Patent

US 9066943

Use of botulinum toxin therapy for treatment of urological neurological conditions

granted A61KA61K31/16A61K31/353

Quick answer

US patent 9066943 (Use of botulinum toxin therapy for treatment of urological neurological conditions) held by The Regents of the University of Colorado expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/16, A61K31/353, A61K38/4893, A61P